Development and Initial Clinical Experience with AltaSeal®: a Novel Hysteroscopically Placed Permanent Contraception System
暂无分享,去创建一个
[1] E. Schiff,et al. In Vitro Fertilization Outcomes After Placement of Essure Microinserts in Patients With Hydrosalpinges Who Previously Failed In Vitro Fertilization Treatment: A Multicenter Study. , 2016, Journal of minimally invasive gynecology.
[2] T. Lawrie,et al. Techniques for the interruption of tubal patency for female sterilisation. , 2016, The Cochrane database of systematic reviews.
[3] I. Thompson,et al. Postpartum Care and Contraception in Obese Women , 2016, Clinical obstetrics and gynecology.
[4] Kenneth J. Smith,et al. Hysteroscopic Essure Inserts for Permanent Contraception: Extended Follow-Up Results of a Phase III Multicenter International Study. , 2016, Journal of minimally invasive gynecology.
[5] J. Jensen,et al. Update on permanent contraception options for women , 2015, Current opinion in obstetrics & gynecology.
[6] J. Jensen,et al. Permanent Contraception for Women , 2015, Women's health.
[7] S. Veersema. Hysteroscopy and contraception. , 2015, Best practice & research. Clinical obstetrics & gynaecology.
[8] H. Brölmann,et al. Effectiveness and feasibility of hysteroscopic sterilization techniques: a systematic review and meta-analysis. , 2015, Fertility and sterility.
[9] P. Crean,et al. First clinical experience with Celt ACD(®) : a femoral arterial puncture closure device. , 2013, Journal of interventional cardiology.
[10] W. Mosher,et al. Current contraceptive use in the United States, 2006-2010, and changes in patterns of use since 1995. , 2012, National health statistics reports.
[11] M. Gannon. I122 FIRST CLINICAL RESULTS OF NEW HYSTEROSCOPIC STERILISATION DEVICE: ALTASEAL , 2012 .
[12] A. Thurkow. AltaSeal Hysteroscopic Sterilization: The New Challenger to Essure? , 2011 .
[13] M. Bongers,et al. Success Rate of the Adiana® Hysteroscopic Sterilization Technique , 2011 .
[14] T. Anderson,et al. The Adiana System for permanent contraception: safety and efficacy at 3 years. , 2011, Journal of minimally invasive gynecology.
[15] D. Galen,et al. Essure multicenter off-label treatment for hydrosalpinx before in vitro fertilization. , 2011, Journal of minimally invasive gynecology.
[16] Andrea Meyer-Lindenberg,et al. Evaluation of the soft tissue biocompatibility of MgCa0.8 and surgical steel 316L in vivo: a comparative study in rabbits , 2010, Biomedical engineering online.
[17] T. Santonen,et al. Review on toxicity of stainless steel , 2010 .
[18] D. Kothwala,et al. Development and assessment of 316LVM cardiovascular stents , 2004 .
[19] C. Carignan,et al. Tissue response to the STOP microcoil transcervical permanent contraceptive device: results from a prehysterectomy study. , 2001, Fertility and sterility.
[20] H. Peterson,et al. Complications of Interval Laparoscopic Tubal Sterilization: Findings From the United States Collaborative Review of Sterilization , 2000, Obstetrics and gynecology.